Literature DB >> 3136561

Induction of red blood cell destruction by graft-derived antibodies after minor ABO-mismatched heart and lung transplantation.

B J Hunt1, M Yacoub, S Amin, A Devenish, M Contreras.   

Abstract

Heart-lung transplantation (HLT) unlike other solid-organ transplants involves transplantation of a large amount of lymphoid tissue; hence there is considerable potential for graft-versus-host reaction if there is an antigen mismatch between donor and recipient. Due to the shortage of suitable donors, minor ABO-mismatched HLT (group O organs given to A, B, or AB recipients) are performed. Of 84 consecutive HLT at Harefield Hospital, nine fully ABO-matched and nine ABO-mismatched HLT were studied. Six minor ABO-mismatched HLT patients had evidence of immune destruction of recipient's red cells. Haemolysis started from days 4-12 and lasted for a mean of 13 days; in four cases transfusion support was necessary. ABO antibodies incompatible with the recipient ABO antigens, but compatible with the donor, were found in the serum and red cell eluates of these patients. In two cases, these antibodies were detected for over one year after transplantation. These changes were not seen in the fully ABO-matched controls. Our findings suggest that donor-derived lymphocytes from group O organs continue to produce anti-A and/or anti-B after transplantation, and if the recipient is group A, B, or AB, mount a secondary immune response following antigenic stimulation by the recipient's differing ABO antigens. The specific transfusion management of these patients is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3136561     DOI: 10.1097/00007890-198808000-00012

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Acute hemolytic anemia in liver and bone marrow transplant patients under FK 506 therapy.

Authors:  K M Abu-Elmagd; O Bronsther; M Kobayashi; A Yagihashi; Y Iwaki; J Fung; M Alessiani; F Bontempo; T Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

2.  Single-lung transplantation in a chronic pulmonary emphysema patient with a marginal donor who was ABO blood group nonidentical but compatible.

Authors:  Yoshiyuki Susaki; Masayoshi Inoue; Masato Minami; Yasushi Shintani; Tomoyuki Nakagiri; Noriyoshi Sawabata; Meinoshin Okumura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-03-28

3.  ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation.

Authors:  Aaron C Logan; Zhiyu Wang; Kamran Alimoghaddam; Ruby M Wong; Tze Lai; Robert S Negrin; Carl Grumet; Brent R Logan; Mei-Jie Zhang; Stephen R Spellman; Stephanie J Lee; David B Miklos
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-05       Impact factor: 5.742

4.  Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source.

Authors:  Sharat Damodar; Ryan Shanley; Margaret MacMillan; Celalettin Ustun; Daniel Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2017-02-14       Impact factor: 5.742

5.  Incidence and pattern of hemolytic anemia after minor ABO-mismatched living-donor lobar lung transplantation.

Authors:  Akihiro Ohsumi; Fengshi Chen; Kimiko Yurugi; Taira Maekawa; Tsuyoshi Shoji; Masaaki Sato; Akihiro Aoyama; Toru Bando; Hiroshi Date
Journal:  Surg Today       Date:  2012-11-23       Impact factor: 2.549

6.  ABO-identical matching has no superiority in long-term survival in comparison to ABO-compatible matching in lung transplantation.

Authors:  Mohammed Fakhro; Hillevi Larsson; Malin Malmsjö; Lars Algotsson; Sandra Lindstedt
Journal:  J Cardiothorac Surg       Date:  2019-01-28       Impact factor: 1.637

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.